BaleDoneen Publications

BOOKS

Bale, B., Doneen, A., Collier Cool, L. (2014). Beat the Heart Attack Gene: The Revolutionary Plan to Prevent Heart Disease, Stroke, and Diabetes. Nashville, TN: Wiley.

PROFESSIONAL PUBLICATIONS

Bale, B.F., Doneen A.D., Vigerust, D.J. (2016) High-risk periodontal pathognes contribute to the pathogenesis of atherosclerosis.  Postgrad Med J. November 29, 2016 as 10.1136.  Open Access BMJ.com.

Cheng, H.G., B.S. Patel, S.S. Martin, M. Blaha, A. Doneen, B.Bale and S.R. Jones (2016). Effect of comprehensive cardiovascular disease risk management on longitudinal changes in carotid artery intima-media thickness in a community based prevention clinic.” Archives of Medical Science 12(4):728-735.

Doneen, A.L., Dupler, A., & Crogan, A. Why the RDH is a critical member of the health-care team. Registered Dental Hygiene Program. February 2014

Doneen, A.L. The direct program: A disease/inflammatory vs risk factor evaluation cardiovascular testing program.  The International Journal of Nursing & Clinical Practices. December 24, 2014.

Doneen, A.L., Dupler, A., & Crogan, N. Cardiovascular wellness and optimal oral health: A symbiotic relationship. Heart Health. November 26, 2014.

Feng, D., Esperat, C., Doneen, A., Bale, B., Song, Hauxin, Green, A. 8 Year Outcomes of a Program for early prevention of cardiovascular events: A growth-curve analysis.  Journal of Cardiovascular Nursing. 2014. 00. No.0.

Bale, B., Doneen. A. A guarantee of arterial wellness; new era of cardiovascular medicine. Clinical & Experimental Cardiology. 2014.

Doneen, A. L., & Bale, B.F. (2013). Carotid intima-media thickness testing as an asymptomatic cardiovascular disease identifier and method for making therapeutic decisions. Postgraduate Medicine125(2),108–23. 2013 doi:10.3810/pgm.2013.03.2645.

Doneen, A. L., & Bale, B. F. (2013). Autophagy, senescence, and arterial inflammation: relationship to arterial health and longevity. Alternative Therapies in Health and Medicine19(4), 8–10.

Mason, C. M., & Doneen, A. L. (2012). Niacin—A critical component to the management of atherosclerosis: contemporary management of dyslipidemia to prevent, reduce, or reverse atherosclerotic cardiovascular disease. Journal of Cardiovascular Nursing27(4), 303–316.  doi:10.1097/JCN.0b013e31821bf93f

Nabors, T., Bale, B., & Doneen, A. (2012). Inculpatory evidence: periodontal disease assessment and treatment is an essential element in cardiovascular wellness programs. Dental Economics102(9), 99.

Jones, P. H., Bale, B., & Doneen, A. (2011). Clinician perspective on the benefits of niacin therapy for the treatment of dyslipidemia and strategies to improve long-term adherence to therapy. The Medical Roundtable—Cardiovascular Edition2(4): 249–55.

Taylor, A. J., Olendorf, M. W., DeMichele, M., Doneen, A. L., Faulkner, D. A., Sutton-Tyrell, K. (2011). Appropriate use criteria for carotid intima media thickness testing,

Society of Atherosclerosis Imaging and Prevention, developed in collaboration with the International Atherosclerosis Society. Atherosclerosis214(1): 43–46. doi:10.1016/j.atherosclerosis.2010.10.045

Bale, B., Doneen, A., & Wegner, M. (2009). The identification of occult cardiovascular disease through the use of a novel biomarker: a case report. Journal of Clinical Lipidology3(5), 351–54. doi:10.1016/j.jacl.2009.08.004 

Bale, B. F., Doneen, A.L., Drueding, R., & Charland, S.L. (2006). Aggressive risk factor modification in patients with sub-clinical atherosclerosis reduces plaque burden and regresses carotid artery wall thickness. Atherosclerosis7(3), 161.

Doneen, A. L., Bale, B. F., Charland, S. L., & Smith, T.F. (2006). Carotid intima-media thickness testing identifies at risk patients missed by Framingham 10-year risk scoring. Atherosclerosis, 7(3), 324.

“Carotid Intima-Media Thickness:  Knowledge and Application to Everyday Practice.” Bale, B. F., Cobble, M. Postgraduate Medicine. January 2010.  122(1): 7-15.

“Optimizing Hypertension Management in Underserved Rural Populations.” Bale, B. F. Journal of National Medical Association. Jan. 2010. 102 (1): 10-17.

“The Identification of Occult Cardiovascular Disease Through the Use of a Novel Biomarker: A Case Report,” Bale, B. F. Journal of Clinical Lipidology, Oct. 2009. 3:  351–354

“Reduce Your Risk of ‘Secret’ Strokes!” Bale, B. F. Women’s World, Oct. 5, 2009, p. 15.

“Markers of Arterial Inflammation.” August 31, 2009, Bale, B. F. Physician’s Weekly, Vol. XXVI Issue No. 33.

“Arterial Inflammation Biomarkers,” [Cover story], Bale, B. F. ADVANCE for Administrators of the Laboratory, July 2009.